and historically 2nd half is better than 1st half.
Posts in category Value Pickr
Filatex India Ltd (29-07-2022)
1500 KgPD Recycling plant along with the upgradation of POY lines has been commissioned on 29/07/2022
Sigachi Industries Limited (29-07-2022)
Thank you for asking great questions over conf - call …
Apar Industries (29-07-2022)
Q1FY’23 Concall Highlights:
General Comments:
150 cr of capex in current fiscal
Higher profitability in FY’23 than previous year
Major exports to US, EU and Australia.
Export contribution can hit 50% of total sales.
New markets opening up for company since many countries adopting China + 1 policy
Aim to achieve 20% RoE. Presently at 17%
Oils:
5500/KL realization in the current fiscal
Resurgence in transformer oil demand
White Oil volume to get hit in Q2 due to higher price. Difficult to pass on
Lubricant demand might fall in long term due to electrification. Battery business acts as hedge
Battery business aims to get higher share of mechanic wallet
Conductors:
Conductors volume target of 130k to 140k tons
Conductors - EBITDA/tonne to be 17k to 17.5k
Interest cost to remain high but built into EBITDA
Cables & Wires:
Aiming for 30% growth in cable business
New e-beam machine go-live in Q3
Cable: target 2600+ cr @ 8.5% margin
Started exporting solar cables to EU
Anushakti launched in 7 states. 200 cr target for wires business
Product differentiation as follows:
Wires have 50% more current carrying capacity than those sold by Polycab and Havells
Insulation of the wire has higher short circuit resistance
RACL Geartech Limited (29-07-2022)
The quarterly revenues are the highest ever. The OPM (19.3%) is better QOQ , however YOY it is lesser. Traditionally Q1 quarter OPM has always been lesser when compared to the rest of the quarters. Overall a satisfactory result.
Godawari Power – Any Trackers? (29-07-2022)
Result is here.
Pretty decent with 25 EPS.
My guess is 15-18 EPS for Q2 (Q2 is weakest quarter due to Monsoons, though 20 EPS can also come, 50 for H2, Total EPS around 90-95 for the year.
At same prices, with double the capacity in 3 years, the EPS should be 200 in FY 26. (and 400 in FY 29, with 4x the capacity)
I would leave price targets and valuations to the market, something which we don’t have any control on.
Dividend from GPIL will be more than my annual expense.
RACL Geartech Limited (29-07-2022)
Decent set
Disc : invested
Route Mobile – Internet, Mobile & Telecom (29-07-2022)
Looks good on the face of it. Although would be waiting to know management explanation of capital allocation post QIP
Tata Power Limited (29-07-2022)
A detailed interview with Mr Praveer Sinha - MD & CEO of Tata Power.
He talks about addition of 2-5 GW renewable capacity every year and capital investment of Rs75000 crore in Solar, Wind , Hydro and Battery storage solution…Here Battery storage solution does not mean Automotive battery. He perhaps refered to the inconsistent production of Renewables energy due to non-availability of Sun light , Wind, Rain throughout the year which are basically of Seasonal nature.
So, here comes battery storage solutions…when there is plenty of Sunlight , wind & Rain in peak seasons , more Renewable energy can be produced and such excess renewable energy can be used to produce Green hydrogen which can be stored and during lean seasons, Green hydrogen can be used to produce electricity with the help of Electrolyser and feed to the Grid.
Then a lot of discussion on Coal availability issues for the existing thermal power plants
Finally, very intersting discussion on Debt of Tata Power … he says Debt is not bad as long as you can service it through cash flow and though they have definite plans to reduce debt and that they would stick to debt equity ratio as specified by Govt for infra companies!
Hitesh portfolio (29-07-2022)
-
Please share your views on how to analyze a generic pharma company product pipeline strength with emerging market exposure?
Everyone posts in their quarterly and yearly reports we have filed these many ANDAs (F2F, DMF etcc ) and all but as a retail investor what is that one parameter ( I think it can’t be one but many ) that can give some insights about the opportunity size? -
Your views on this buzz word in Pharma CDMO.
-
As per Pharma experts (dedicated PMS into pharma) they don’t favor companies with US exposure due to pricing erosion, but high margins are achieved beyond a level only by going to emerging markets. Please share your thoughts
-
Gland - In the concall Mr. Sadu said impact is due to syringe supply constraints, but in Reddys latest concall, they said there is no such issue experienced by them. (It is evident there is huge demand for syringes all over the world for vaccines ) How to understand these kind of statements (in terms of management honesty / integrity ) ?
Many Thanks